- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | iZafe Group AB: October monthly letter - customer implementations and next steps under existing agreements | 160 | GlobeNewswire (Europe) | During October, we continued to convert our agreements and partner relationships into customer implementations. A customer implementation has started as part of the collaboration with Atea, work on... ► Artikel lesen | |
| 03.11. | iZafe Group AB: iZafe Group's Interim Report Q3, July-September 2026 | 169 | GlobeNewswire (Europe) | iZafe Group AB (publ.) today, November 3, presents its report for the third quarter of 2026.
Financial Performance in SummaryThe Group's net sales for the quarter amounted to 1,768 (1,102) TSEK. The... ► Artikel lesen | |
| 08.10. | iZafe Group AB: September Monthly Update - New Municipal Agreements and Launch in Iceland | 159 | GlobeNewswire (Europe) | September brought new municipal agreements in Sweden and the commercial launch of Dosell in Iceland. At the same time, deliveries from the ongoing production batch continued, alongside further work... ► Artikel lesen | |
| 23.09. | iZafe Group AB: Dosell launches in Iceland through Lyfja and SKAND | 361 | GlobeNewswire (Europe) | iZafe Group AB (publ) today announces that Dosell is now commercially available in Iceland through the pharmacy chain Lyfja and local distribution partner SKAND. The launch marks the commercial activation... ► Artikel lesen | |
| 16.09. | iZafe Group AB: Dosell wins new municipal contract under Adda's framework agreement - Mora, Orsa and Älvdalen | 315 | GlobeNewswire (Europe) | iZafe Group AB (publ) today announces that its wholly owned subsidiary Dosell AB has entered into an agreement with the municipalities of Mora, Orsa and Älvdalen after being selected as the winning... ► Artikel lesen | |
| 07.09. | iZafe Group AB: Monthly Letter August - Production Underway and Focus on Autumn Implementations | 333 | GlobeNewswire (Europe) | August, as is normally the case during the summer holiday period, was a quieter month in terms of new implementations. At the same time, production of the new batch of approximately 1,300 Dosell units... ► Artikel lesen | |
| 31.08. | iZafe Group AB: iZafe Group's interim report for the second quarter of 2026, April-June 2026 | 283 | GlobeNewswire (Europe) | iZafe Group AB (publ.) today presents its report for the second quarter of 2026, on August 31.
Financial Performance in SummaryThe Group's net sales for the quarter amounted to 2,639 (1,136) TSEK. Net... ► Artikel lesen | |
| IZAFE GROUP Aktie jetzt für 0€ handeln | |||||
| 10.07. | iZafe Group AB: iZafe Group AB carries out the first partial payment for the acquisition of its Dutch subsidiary through a set-off issue of B shares | 280 | GlobeNewswire (Europe) | In September 2025, iZafe Group AB, reg. no. 556762-3391 ("iZafe" or the "Company"), acquired the Dutch company Thuisapparatuur Nederland B.V. ("TAN"). iZafe has today entered into an addendum agreement... ► Artikel lesen | |
| 07.07. | iZafe Group: June Monthly Letter - Strong Pipeline and Preparations for An Intensive Autumn | 398 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / July 7, 2026 / iZafe Group (STO:IZAFE-B) - June was a month in which we continued to build on the increased activity we have seen during the spring. At the same time... ► Artikel lesen | |
| 26.06. | iZafe Group's CEO Transfers Shares Privately to Enable Participation in LTIP 2026:I | 433 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / June 26, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) announces that the company's CEO, Anders Segerström, has transferred 900,901 B shares in iZafe Group... ► Artikel lesen | |
| 08.06. | iZafe Group: May Monthly Letter: Continued Scaling and Increased Utilisation | 409 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / June 8, 2026 / iZafe Group (STO:IZAFE-B) - May was a month in which we continued to build on the foundation established during the spring. Following the entry into... ► Artikel lesen | |
| 08.05. | iZafe Group: Monthly Letter April - Increased Activity and Growing Implementations | 756 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / May 8, 2026 / iZafe Group (STO:IZAFE-B) - April was characterized by a high level of activity across several areas. We continue to see strong interest in Dosell, both... ► Artikel lesen | |
| 28.04. | iZafe Group Q1 Interim Report, January-March 2026 | 424 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 28, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) presents today, April 28th, its report for the first quarter.Financial Performance in SummaryThe... ► Artikel lesen | |
| 23.04. | iZafe Group: Dosell Awarded Contract with Västervik Municipality Regarding Medication Dispensing Devices | 380 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 23, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) announces that its subsidiary Dosell AB, together with Atea Sverige AB, has been awarded a contract... ► Artikel lesen | |
| 13.04. | iZafe Group Achieves ISO/IEC 27001 Certification and Strengthens Its Position for International Expansion | 488 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 13, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) today announces that the company has obtained certification according to the international ISO/IEC... ► Artikel lesen | |
| 10.04. | iZafe Group: Monthly Update March - ADDA in Effect and Preparations for the Next Growth Phase | 567 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 10, 2026 / iZafe Group (STO:IZAFE-B) - March has been a month where several important milestones have been achieved for iZafe Group. The ADDA framework agreement... ► Artikel lesen | |
| 07.04. | iZafe Group: Dosell AB Awarded Contract with Region Jönköping County and its Municipalities | 498 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 7, 2026 / iZafe Group AB (publ)(STO:IZAFE-B) today announces that its subsidiary Dosell AB has been awarded a sub-contract within Region Jönköping County's procurement... ► Artikel lesen | |
| 01.04. | iZafe Group: Dosell AB Granted European Patent in Data-Driven Medication Management | 442 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 1, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) today announces that its subsidiary Dosell AB has been granted a European patent, EP4228584, titled... ► Artikel lesen | |
| 12.03. | iZafe Group: Dosell AB Signs Framework Agreement with Adda Following the End of the Appeal Period | 622 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / March 12, 2026 / iZafe Group (STO:IZAFE-B) today announces that its subsidiary Dosell AB has signed a framework agreement with Adda Inköpscentral following the... ► Artikel lesen | |
| 12.03. | The observation status for iZafe Group AB is removed | 448 | GlobeNewswire | On February 17, 2026, the shares in iZafe Group AB (the "Company") were given observation status with reference to uncertainty in respect of the issuer's financial position.
On February 19, 2026... ► Artikel lesen |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 53,62 | +0,62 % | EQS-DD: Fresenius SE & Co. KGaA: Dr. Christian Pawlu, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
09.11.2026 / 09:49... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,110 | +1,39 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Fresenius Medical Care (FMC) von 38 auf 37,50 Euro gesenkt und die Einstufung auf "Neutral" belassen. Analyst Richard... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,950 | +0,34 % | BARCLAYS stuft Siemens Healthineers auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Siemens Healthineers von 47,50 auf 51 Euro angehoben und die Einstufung auf "Overweight" belassen. Analyst Hassan... ► Artikel lesen | |
| HEARTFLOW | 48,880 | -18,42 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| STARLING ONCOLOGY INSTITUTE | 3,620 | -3,47 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| OTTOBOCK | 40,050 | +2,17 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): 9-Monatszahlen
Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort
12.11.2026 / 07:30 CET/CEST
Für den... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 70,37 | -1,51 % | BrightSpring, Centene stand out as healthcare's most persistent Strong Buys | ||
| ECKERT & ZIEGLER | 15,340 | +5,79 % | EQS-News: Eckert & Ziegler SE: Bereinigtes EBIT im dritten Quartal +25%. Prognose 2026 bestätigt | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): 9-Monatszahlen
Eckert & Ziegler: Bereinigtes EBIT im dritten Quartal +25%. Prognose 2026 bestätigt
12.11.2026 / 07:45 CET/CEST
Für... ► Artikel lesen | |
| NEUROPACE | 6,340 | -47,25 % | Warum die NeuroPace-Aktie heute um fast 40 % einbricht | ||
| BILLIONTOONE | 107,77 | -2,73 % | BillionToOne auf der Stifel Healthcare Conference 2026: Wachstumsdynamik gewinnt an Breite | ||
| GENEDX | 50,74 | -2,21 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences:... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 11,360 | -7,08 % | RBC Capital reiterates Aveanna Healthcare stock rating at Outperform | ||
| LIFESTANCE HEALTH GROUP | 13,970 | -1,27 % | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | ||
| DRAEGERWERK | 112,00 | +0,90 % | BERENBERG stuft Draegerwerk auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Bewertung von Drägerwerk beim Kursziel von 156 Euro mit "Buy" aufgenommen. Beim Medizin- und Sicherheitstechnik winke ein massiver Profitabilitätsschub... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,000 | +1,63 % | 0,60 Dioptrien weniger Fortschreiten: Warum ZEISS bei Kinderbrillen auf dynamische Signale setzt |
IZAFE GROUP AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (-2,00 %) liegt der Kurs bei 0,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IZAFE GROUP AB finden Sie auf Wallstreet Online.